Reactive nitrogen and oxygen species in airway inflammation

European Journal of Pharmacology

Volumn 429, Issue 1-3, 2001, Pages 251-262

  Folkerts, Gert ^a   Kloek, Joris ^a   Muijsers, Richard B R ^a   Nijkamp, Frans P ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Airway; Lung; Nitric oxide (NO); Peroxynitrite; Radical; Super oxide

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; APOCYNIN; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROGEN DERIVATIVE; OXIDIZING AGENT; PEROXYNITRITE; REACTIVE NITROGEN METABOLITE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE INHIBITOR; SD 3651; SUPEROXIDE; UNCLASSIFIED DRUG;

AIRWAY; ALLERGY; ASTHMA; BRONCHODILATATION; CONCENTRATION RESPONSE; DESTRUCTION; HOST; HUMAN; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; NITROSATION; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; STRESS; T LYMPHOCYTE;

ANIMALS; HUMANS; INFLAMMATION; LUNG; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 0035840819     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01324-3     Document Type: Review

References (120)

1. Plasma nitrate as an index of NO formation in patients with acute infectious diseases
2. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+
3. Phenotyping and cytokine regulation of the BEAS-2B human bronchial epithelial cell: Demonstration of inducible expression of the adhesion molecules VCAM-1 and ICAM-1
4. Oxygen dependent microbial killing by phagocytes
5. Regulation of inducible and neuronal NO synthase gene expression by interferon-gamma and VIP
6. NO or no NO in asthma?
7. NO and asthmatic inflammation
8. NO, superoxide, and peroxynitrite: The good, the bad, and the ugly
9. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from NO and superoxide
10. Reaction of superoxide with NO to form peroxynitrite in alkaline aqueous solution
11. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects
12. NO increased interleukin-4 expression in T lymphocytes
13. Rapid inactivation of NOS-I by lipopolysaccharide plus interferon-gamma-induced tyrosine phosphorylation
14. Effects of endogenous superoxide anion and NO on cholinergic constriction of normal and hyperreactive guinea pig airways
15. Exhaled NO (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma
16. Interferon-γ activates superoxide anion production in blood monocytes from allergic asthmatic patients
17. Contribution of NO synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma
18. Exhaled NO correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma
19. Formation of NO-derived inflammatory oxidants by myeloperoxidase in neutrophils
20. Pathophysiology of NO and related species: Free radical reactions and modification of biomolecules
21. The effects of a selective inhibitor of inducible NO synthase in a brown-Norway rat model of allergic asthma
22. Mechanisms of NO-related antimicrobial activity
23. Perspectives series: Host/pathogen interactions. Mechanisms of NO-related antimicrobial activity
24. Role of NO on eosinophilic lung inflammation in allergic mice
25. NO modulates eosinophil infiltration in antigen-induced airway inflammation in rats
26. Airway epithelium: More than just a barrier!
27. Variants of NOS1, NOS2, and NOS3 genes in asthmatics
28. Airway eosinophils, T cells, Th2-type cytokine mRNA, and hyperreactivity in response to aerosol challenge of allergic mice with previously established pulmonary inflammation
29. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo
30. NO and thiol groups
31. The biology of nitrogen oxides in the airways
32. 2: A pulse radiolysis study
33. NO and peroxynitrite-mediated pulmonary cell death
34. Neuronal NO synthase (NOS1) is a major candidate gene for asthma
35. Continuous NO synthesis by inducible NO synthase in normal human airway epithelium in vivo
36. Interferon gamma and interleukin 4 stimulate prolonged expression of inducible NO synthase in human airway epithelium through synthesis of soluble
37. Molecular mechanisms of increased NO (NO) in asthma: Evidence for transcriptional and post-translational regulation of NO synthesis
38. Induction of NO synthase in asthma
39. Acid-dependent dismutation of nitrogen oxides may be a critical source of NO in human macrophages
40. Formation of NO-derived oxidants by myeloperoxidase in monocytes: Pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo
41. Development of airway hyperresponsiveness is dependent on interferon-γ and independent of eosinophil infiltration
42. Inhibition of NO synthase as a potential therapeutic target
43. Differential effects of endogenous and exogenous interferon-γ on immunoglobulin E, cellular infiltration, and airway responsiveness in a murine model of allergic asthma
44. The reaction of no with superoxide
45. Endogenous airway acidification. Implications for asthma pathophysiology
46. Role of endogenous NO in allergen-induced airway responses in guinea-pigs
47. Implication of oxygen radicals on airway hyperresponsiveness after ovalbumin challenge in guinea pigs
48. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma
49. Structural alterations and inflammation of bronchi in asthma
50. Activities of superoxide dismutases and NADPH oxidase in neutrophils obtained from asthmatic and normal donors
51. Cholinergic contraction is altered in nNOS knockouts. Cooperative modulation of neural bronchoconstriction by nnos and cox
52. Effects of TNF-α, interferon-γ and IL-β on normal human bronchial epithelial cells
53. NO metabolism and breakdown
54. Peroxynitrite and myeloperoxidase leave the same footprint in protein nitration
55. Inhaled glucocorticoids decrease NO in exhaled air of asthmatic patients
56. Changes in the dose of inhaled steroid affect exhaled NO levels in asthmatic patients
57. Interleukin-4 stimulates cGMP production by interferon-γ activated human monocytes. Involvement of the NO synthase pathway
58. Role of CD23 in NO production by human monocytic cells
59. Autoinhibition of neuronal NO synthase: Distinct effects of reactive nitrogen and oxygen species on enzyme activity
60. Role of NO in central synaptic transmission: Effects on neurotransmitter release
61. Regulation of NANC neural bronchoconstriction in vivo in the guinea-pig: Involvement of NO, vasoactive intestinal peptide and soluble guanylyl cyclase
62. Regulation of lymphocyte functions by NO
63. Inducible NO synthase after sensitization and allergen challenge of Brown Norway rat lung
64. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible NO synthase
65. Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals
66. Lessons from genetically engineered animal models: IV. NO synthase gene knockout mice
67. Elevated NO concentrations in isolated lower airway gas of asthmatic subjects
68. Antimicrobial actions of the NADPH phagocyte oxidase and inducible no synthase in experimental Salmonellosis: II. Effects on microbial proliferation and host survival in vivo
69. The utility of superoxide dismutase in studying free radical reactions
70. Acute and chronic effects of allergic airway inflammation on pulmonary NO production
71. Selective inhibition of the inducible NO synthase by aminoguanidine
72. Biosynthesis of NO from L-arginine: A pathway for the regulation of cell function and communication
73. NO: Physiology, pathophysiology and pharmacology
74. Peroxynitrite: A two-faced metabolite of NO
75. Apocynin inhibits peroxynitrite formation by murine macrophages
76. Inhibitors of both NADPH-oxidase and NO synthase prevent airway hyperresponsivenss but not allergic inflammation in a murine model of asthma
77. L-Arginine is not the limiting factor for NO synthesis by human alveolar macrophages in vitro
78. NO and cell death
79. NO activates metalloprotease enzymes in articular cartilage
80. NO as a secretory product of mammalian cells
81. NO synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Role of the epithelium
82. Nitrogen oxide levels in patients after trauma and during sepsis
83. Nitration of unsaturated fatty acids by NO-derived reactive species
84. Analysis of 3-nitrotyrosine in biological fluids and protein hydrolyzates by high-performance liquid chromatography using a postseparation, on-line reduction column and electrochemical detection: Results with various nitrating agents
85. Peroxynitrite formed by simultaneous NO and superoxide generation causes cyclosporin-A-sensitive mitochondrial calcium efflux and depolarisation
86. Constitutive expressions of type I NOS in human airway smooth muscle cells: Evidence for an antiproliferative role
87. The chemistry of peroxynitrite: A product from the reaction of NO with superoxide
88. Production of NO by rat type II pneumocytes: Increased expression of inducible NO synthase following inhalation of a pulmonary irritant
89. Dexamethasone prevents the induction of a NO synthase and the associated effects on vascular tone: An insight into endotoxin shock
90. Superoxide reacts with NO to nitrate tyrosine at physiological pH via peroxynitrite
91. Expression of inducible NO in human lung epithelial cells
92. NO selectively decreases interferon-γ expression by activated human T lymphocytes via a cGMP-independent mechanism
93. Regulation and role of interferon-γ in the innate resistance to infection with Chlamydia pneumoniae
94. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of NO synthase: Effect of inhaled glucocorticoid
95. NO synthase in models of focal ischemia
96. Dual action of iNOS-derived NO in allergen-induced airway hyperreactivity in conscious, unrestrained guinea pigs
97. Role of NO in the development and partial reversal of allergen-induced airway hyperreactivity in conscious, unrestrained guinea-pigs
98. NO exposure inhibits endothelial NOS activity but not gene expression: A role for superoxide
99. NO as a neuronal messenger
100. Selective pharmacological inhibition of distinct NO synthase isoforms
101. Oral administration of the NO biosynthesis inhibitor, N-nitro-L-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance, in rats
102. Exhaled NO is higher both at day and night in subjects with nocturnal asthma
103. Inducible NO synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression
104. Differential effects of NO synthase inhibitors in an in vivo allergic rat model
105. Acceleration of peroxynitrite oxidations by carbon dioxide
106. Reactive nitrogen species and tyrosine nitration in the respiratory tract: Epiphenomena or a pathobiologic mechanism of disease?
107. Involvement of an NAD(P)H oxidase-like enzyme in superoxide anion and hydrogen peroxide generation by rat type II cells
108. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon-γ-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation
109. Modulation of cholinergic neural bronchoconstriction by endogenous NO and vasoactive intestinal peptide in human airways in vitro
110. Distribution of human i-NANC bronchodilator and NO-immunoreactive nerves
111. Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by NO
112. Altered immune responses in mice lacking inducible nitric-oxide synthase
113. NO production and NO synthase type 2 expression by human mononuclear phagocytes: A review
114. Human mononuclear phagocyte inducible NO synthase (iNOS): Analysis of iNOS mRNA, iNOS protein, biopterin, and NO production by blood monocytes and peritoneal macrophages
115. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders
116. NO synthase generates superoxide and NO in arginine-depleted cells leading to peroxynitrite-mediated cellular injury
117. Inhibition of allergic airway inflammation in mice lacking NO synthase 2
118. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon-γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects
119. Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide
120. Non-enzymatic NO synthesis in biological systems